Tacrolimus

transforming growth factor beta 1 ; Homo sapiens







43 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33938785 Improving Right Ventricular Function by Increasing BMP Signaling with FK506. 2021 Sep 1
2 33206751 Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide. 2020 1
3 30633591 Effects of tacrolimus (FK506) and mycophenolate mofetil (MMF) on regulatory T cells and co-inhibitory receptors in the peripheral blood of human liver allograft patients. 2019 Jun 1
4 28060893 Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis. 2017 2
5 28901186 Recipient Adipose-Derived Stem Cells Enhance Recipient Cell Engraftment and Prolong Allotransplant Survival in a Miniature Swine Hind-Limb Model. 2017 Aug 2
6 27128949 Tacrolimus Modulates TGF-β Signaling to Induce Epithelial-Mesenchymal Transition in Human Renal Proximal Tubule Epithelial Cells. 2016 Apr 26 3
7 27372923 Transforming growth factor β-related genes in human retinal pigment epithelial cells after tacrolimus treatment. 2016 Oct 4
8 25964218 Relationship of Interleukin-10 and Transforming Growth Factor-β Levels With Short-Term Graft Function After Kidney Transplantation. 2015 Jun 1
9 23301526 Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions. 2014 Feb 10
10 24816588 Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling. 2014 5
11 22540338 FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach. 2012 Sep 15
12 22743729 Tacrolimus-induced nephrotoxicity and genetic variability: a review. 2012 Apr-Jun 3
13 21310938 Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells. 2011 May 2
14 19604038 Calcineurin inhibitors promote chondrogenic marker expression of dedifferentiated human adult chondrocytes via stimulation of endogenous TGFbeta1 production. 2010 Jan 4
15 18342291 Gingival crevicular fluid transforming growth factor-beta1 in cyclosporine and tacrolimus treated renal transplant patients without gingival overgrowth. 2008 Aug 2
16 18349138 FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation. 2008 Aug 1 2
17 18355347 Transforming growth factor-beta1 gene expression and cyclosporine A-induced gingival overgrowth: a pilot study. 2008 May 3
18 18492692 The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells. 2008 Jul 3
19 18589121 A therapeutic dose of FK506 does not affect collagen turnover pathways in healthy human gingival fibroblasts. 2008 Jun 1
20 17292639 The immunosuppressant FK506 promotes development of the chondrogenic phenotype in human synovial stromal cells via modulation of the Smad signaling pathway. 2007 Jun 1
21 16458528 FK506, transforming growth factor-beta1 and mesangial matrix synthesis: parallels and differences compared with cyclosporine A. 2006 Jan 21 3
22 16507844 Use of tacrolimus, a potent antifibrotic agent, in bleomycin-induced lung fibrosis. 2006 Mar 1
23 16671880 The relationship of transforming growth factor-beta1 gene polymorphism, its plasma level, and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens. 2006 May 3
24 16773453 The effects of tacrolimus ointment on regulatory T lymphocytes in atopic dermatitis. 2006 Jul 2
25 29539165 The Relationship of Transforming Growth Factor-β1 Gene Polymorphism, Its Plasma Level, and Gingival Overgrowth in Renal Transplant Recipients Receiving Different Immunosuppressive Regimens. 2006 May 3
26 15694998 Impact of TGFbeta1 gene polymorphisms on late renal function in pediatric heart transplantation. 2005 Feb 1
27 15716327 Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1. 2005 May 4
28 15818662 Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts. 2005 Apr 1
29 15377358 FK506 independently upregulates transforming growth factor beta and downregulates inducible nitric oxide synthase in cultured human keratinocytes: possible mechanisms of how tacrolimus ointment interacts with atopic skin. 2004 Sep 5
30 12646197 The immunosuppressive agent tacrolimus induces p21WAF/CIP1WAF1/CIP1 via TGF-beta secretion. 2003 Mar 28 3
31 11849412 Molecular and structural consequences of early renal allograft injury. 2002 Feb 2
32 12352326 Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril. 2002 Oct 1
33 12427154 Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. 2002 Dec 1
34 10755567 TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus. 2000 Mar 15 3
35 10972232 Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. 2000 Aug 27 3
36 11112017 Active TGF-beta1 expression in kidney transplantation: a comparative study of cyclosporin-A (CyA) and tacrolimus (FK506). 2000 1
37 10071036 Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. 1999 Feb 27 2
38 10480422 Blood levels of TGFbeta1 in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine. 1999 Aug 27 3
39 9665007 Differential effects of cyclosporin A and tacrolimus on the production of TGF-beta: implications for the development of obliterative bronchiolitis after lung transplantation. 1998 3
40 9715421 FK506 promotes liver regeneration by suppressing natural killer cell activity. 1998 Jul 2
41 9422408 Posttransplant diastolic hypertension: associations with intragraft transforming growth factor-beta, endothelin, and renin transcription. 1997 Dec 27 2
42 7545487 Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. 1995 May 2
43 1380951 The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells. 1992 Jul 2